Veracyte Inc (VCYT)
21.67
-0.32
(-1.46%)
USD |
NASDAQ |
Jun 28, 16:00
21.67
0.00 (0.00%)
After-Hours: 20:00
Veracyte Accounts Receivable (Quarterly): 46.66M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 46.66M |
December 31, 2023 | 40.38M |
September 30, 2023 | 39.30M |
June 30, 2023 | 42.36M |
March 31, 2023 | 45.49M |
December 31, 2022 | 44.02M |
September 30, 2022 | 40.07M |
June 30, 2022 | 40.45M |
March 31, 2022 | 42.48M |
December 31, 2021 | 41.46M |
September 30, 2021 | 40.31M |
June 30, 2021 | 31.86M |
March 31, 2021 | 27.88M |
December 31, 2020 | 18.46M |
September 30, 2020 | 17.63M |
June 30, 2020 | 15.31M |
March 31, 2020 | 19.09M |
December 31, 2019 | 19.33M |
September 30, 2019 | 23.61M |
June 30, 2019 | 19.63M |
March 31, 2019 | 16.62M |
December 31, 2018 | 13.17M |
September 30, 2018 | 12.26M |
Date | Value |
---|---|
June 30, 2018 | 13.01M |
March 31, 2018 | 13.20M |
December 31, 2017 | 12.72M |
September 30, 2017 | 11.64M |
June 30, 2017 | 11.03M |
March 31, 2017 | 9.125M |
December 31, 2016 | 8.756M |
September 30, 2016 | 6.312M |
June 30, 2016 | 3.387M |
March 31, 2016 | 3.23M |
December 31, 2015 | 3.503M |
September 30, 2015 | 3.52M |
June 30, 2015 | 3.586M |
March 31, 2015 | 2.564M |
December 31, 2014 | 3.05M |
September 30, 2014 | 1.18M |
June 30, 2014 | 1.43M |
March 31, 2014 | 1.191M |
December 31, 2013 | 1.143M |
September 30, 2013 | 0.714M |
June 30, 2013 | 0.991M |
December 31, 2012 | 0.569M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
15.31M
Minimum
Jun 2020
46.66M
Maximum
Mar 2024
32.79M
Average
39.68M
Median
Accounts Receivable (Quarterly) Benchmarks
Fonar Corp | 26.92M |
XWELL Inc | 2.90M |
ProPhase Labs Inc | 35.12M |
Applied DNA Sciences Inc | 0.4089M |
OncoCyte Corp | 0.161M |